The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
113938666 11393866 6 F 20160812 20150819 20160823 EXP CA-ROCHE-1622898 ROCHE 0.00 F Y 0.00000 20160823 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
113938666 11393866 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 225 MG SOLUTION FOR INJECTION QOW
113938666 11393866 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E,S0001E 103976 SOLUTION FOR INJECTION
113938666 11393866 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E,S0001E 103976 SOLUTION FOR INJECTION
113938666 11393866 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E,S0001E 103976 SOLUTION FOR INJECTION
113938666 11393866 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E,S0001E 103976 SOLUTION FOR INJECTION
113938666 11393866 6 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown U 0
113938666 11393866 7 C SINGULAIR MONTELUKAST SODIUM 1 Unknown U 0
113938666 11393866 8 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 0
113938666 11393866 9 C REACTINE (CANADA) CETIRIZINE HYDROCHLORIDE 1 Unknown U 0
113938666 11393866 10 C BECONASE AQ BECLOMETHASONE DIPROPIONATE MONOHYDRATE 1 Unknown U 0
113938666 11393866 11 C VENTOLIN ALBUTEROL SULFATE 1 Unknown U 0
113938666 11393866 12 C PANTOLOC PANTOPRAZOLE SODIUM 1 Unknown U 0
113938666 11393866 13 C GABAPENTIN. GABAPENTIN 1 Unknown U 0
113938666 11393866 14 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
113938666 11393866 1 Asthma
113938666 11393866 6 Product used for unknown indication
113938666 11393866 7 Product used for unknown indication
113938666 11393866 8 Product used for unknown indication
113938666 11393866 9 Product used for unknown indication
113938666 11393866 10 Product used for unknown indication
113938666 11393866 11 Product used for unknown indication
113938666 11393866 12 Product used for unknown indication
113938666 11393866 13 Product used for unknown indication
113938666 11393866 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
113938666 11393866 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
113938666 11393866 Anaphylactic reaction
113938666 11393866 Asthenia
113938666 11393866 Back pain
113938666 11393866 Diarrhoea
113938666 11393866 Dyspnoea
113938666 11393866 Fatigue
113938666 11393866 Forced expiratory volume decreased
113938666 11393866 Functional gastrointestinal disorder
113938666 11393866 Gastric dilatation
113938666 11393866 Hypoventilation
113938666 11393866 Middle insomnia
113938666 11393866 Muscular weakness
113938666 11393866 Productive cough
113938666 11393866 Sputum discoloured
113938666 11393866 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
113938666 11393866 1 20150810 0
113938666 11393866 2 20160418 0
113938666 11393866 3 20160615 0
113938666 11393866 4 20160628 0
113938666 11393866 5 20160714 0